Taofeek Owonikoko, MD
Enriched profileKevin J. Cullen, M.D. Distinguished Professor of Oncology; Executive Director, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center; Chief of Service, University of Maryland Medical Center; Senior Associate Dean for Cancer Programs and Associate Vice President for Cancer Programs, University of Maryland School of Medicine / UMB · University of Maryland School of Medicine
Taofeek Owonikoko is Kevin J. Cullen, M.D. Distinguished Professor of Oncology; Executive Director, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center; Chief of Service, University of Maryland Medical Center; Senior Associate Dean for Cancer Programs and Associate Vice President for Cancer Programs, University of Maryland School of Medicine / UMB at University of Maryland School of Medicine. OpenAlex indexes 708 publications with 66,624 citations (h-index 89); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Taofeek Kunle Owonikoko, MD, is Kevin J. Cullen, M.D. Distinguished Professor of Oncology at University of Maryland School of Medicine / University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), Baltimore, MD. The public record shows 708 publications with 66,624 citations (h-index 89), centered on Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 29 companies, 4 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · JCO oncology practice
- Top research focus: Lung Cancer Treatments and Mutations
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 35 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 262.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Sponsor: University of Maryland, Baltimore
- Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
Sponsor: University of Maryland, Baltimore
Industry payments
Updated 27 Aug 2026
29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
- F. Hoffmann-La Roche AGProgram year20252 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
32.1%l-Thyroxine32.1%Levothyroxine Sodium100%Part D<11 patientsNervous system
25%Phenothiazine25%Prochlorperazine Maleate100%Part D<11 patientsMetabolism & gastrointestinal
21.4%Serotonin-3 Receptor Antagonist21.4%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer
University of Maryland Baltimore
FY2026$646,115R01CA273216 - UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT
University of Maryland Baltimore
FY2025$2,317,500P30CA134274 - Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer
University of Maryland Baltimore
FY2025$648,269R01CA273216
Congress activity
Updated 27 Aug 2026
188 congress contributions (2009–2025) across AACR, ASCO, ASTRO, ENDO, ESMO per OpenAlex. The most recent:
- Career transitions and practice patterns among international medical graduates in oncology workforce: A US nationwide analysis.
ASCO Annual Meeting
ASCO2025Co-author - International medical graduates (IMGs) in leadership roles within academic oncology in the United States (US).
ASCO Annual Meeting
ASCO2025Co-author - Recognizing international medical graduates: Awards and committee membership in ASCO.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.
Journal of clinical oncology
Clinical Trial2026 - Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer.
JCO oncology practice
Article2026
Most-cited works
by citation count (OpenAlex)- 01The Immune Landscape of CancerArticle6,255 citations2018
- 02An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsArticle3,980 citations2018
- 03Oncogenic Signaling Pathways in The Cancer Genome AtlasArticle3,392 citations2018
- 04Genomic Classification of Cutaneous MelanomaArticle3,267 citations2015
- 05Integrated Genomic Characterization of Papillary Thyroid CarcinomaArticle3,096 citations2014
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
- MS in Clinical Research
James T. Laney School of Graduate Studies, Emory University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗ - Board Certified
Hematology and Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pittwire.pitt.edu ↗
Editorial & leadership roles
journal and society appointments- Executive Director
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗ - Kevin J. Cullen
M.D. Distinguished Professor of Oncology / Marlene and Stewart Greenebaum Professor in Oncology, Department of Medicine, University of Maryland School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗ - Chief of Service
University of Maryland Medical Center (UMMC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.umgccc.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →baltimoresun.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.umaryland.edu ↗
- Heine Hansen Award for Small Cell Lung Cancer Research
International Association for the Study of Lung Cancer (IASLC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.umaryland.edu ↗
Secondary affiliations
appointments beyond the home institution- Former Chief
Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine / UPMC Hillman Cancer Center
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dom.pitt.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittwire.pitt.edu ↗
- Former Associate Director for Translational Research and Co-Leader
Cancer Therapeutics Program, UPMC Hillman Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dom.pitt.edu ↗
Media & interviews
press, podcasts and appearances- Podcast guest
'The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty,' The Cancer Letter Podcast
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerletter.com ↗ - Featured profile
'What's on Greenebaum Cancer Center Executive Director Taofeek K. Owonikoko's Desk?', The Elm / Catalyst Magazine
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →elm.umaryland.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Hochberg, MD
University of Maryland School of Medicine
Robert Redfield, MD
University of Maryland School of Medicine
Robert Buchanan, MD
University of Maryland School of Medicine